Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Pavia

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Crohn'S & Colitis|May 13, 2022
What Can IBD Specialists Learn from IL-23 Trials in Dermatology?Mario Valenti, Alessandra Narcisi, Giulia Pavia, et al.
Dermatology Reports|April 16, 2024
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeksLuciano Ibba, Luigi Gargiulo, Giulia Pavia, et al.
The Journal of Dermatological Treatment|February 22, 2023
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case seriesLuigi Gargiulo, Luciano Ibba, Giulia Pavia, et al.
Journal of Cutaneous Pathology|November 27, 2019
Specific infiltrate of Hodgkin lymphoma at site of cellulitis mimicking secondary cutaneous involvementPaola Facheris, Mario Valenti, Giulia Pavia, et al.
Dermatologic Therapy|April 15, 2020
Brodalumab: A new way to inhibit IL-17 in psoriasisPaola Facheris, Mario Valenti, Giulia Pavia, et al.
Dermatology and Therapy|April 23, 2022
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective StudyLuigi Gargiulo, Giulia Pavia, Mario Valenti, et al.
Dermatologic Therapy|November 25, 2021
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative studyAlessandra Narcisi, Mario Valenti, Andrea Cortese, et al.
Dermatologic Therapy|December 8, 2021
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective studyGiulia Pavia, Luigi Gargiulo, Andrea Cortese, et al.
Melanoma Research|October 8, 2021
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapyLuigi Gargiulo, Maria Chiara Tronconi, Maria S Grimaudo, et al.
International Journal of Dermatology|March 5, 2021
Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospitalMario Valenti, Giulia Pavia, Luigi Gargiulo, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Crohn'S & Colitis|May 13, 2022
What Can IBD Specialists Learn from IL-23 Trials in Dermatology?Mario Valenti, Alessandra Narcisi, Giulia Pavia, et al.
Dermatology Reports|April 16, 2024
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeksLuciano Ibba, Luigi Gargiulo, Giulia Pavia, et al.
The Journal of Dermatological Treatment|February 22, 2023
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case seriesLuigi Gargiulo, Luciano Ibba, Giulia Pavia, et al.
Journal of Cutaneous Pathology|November 27, 2019
Specific infiltrate of Hodgkin lymphoma at site of cellulitis mimicking secondary cutaneous involvementPaola Facheris, Mario Valenti, Giulia Pavia, et al.
Dermatologic Therapy|April 15, 2020
Brodalumab: A new way to inhibit IL-17 in psoriasisPaola Facheris, Mario Valenti, Giulia Pavia, et al.
Dermatology and Therapy|April 23, 2022
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective StudyLuigi Gargiulo, Giulia Pavia, Mario Valenti, et al.
Dermatologic Therapy|November 25, 2021
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative studyAlessandra Narcisi, Mario Valenti, Andrea Cortese, et al.
Dermatologic Therapy|December 8, 2021
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective studyGiulia Pavia, Luigi Gargiulo, Andrea Cortese, et al.
Melanoma Research|October 8, 2021
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapyLuigi Gargiulo, Maria Chiara Tronconi, Maria S Grimaudo, et al.
International Journal of Dermatology|March 5, 2021
Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospitalMario Valenti, Giulia Pavia, Luigi Gargiulo, et al.
Pageof 2